Canadian Cannabis Legalization Linked to Tens of Thousands of Estimated Annual Deaths—But the Numbers Require Careful Scrutiny
Cannabis-associated health risks contribute to an estimated 28,000 to 30,000 premature deaths annually in Canada. These figures derive from population-attributable fraction modelling rather than direct causal attribution. Understanding…
Daily Cannabis Users Under 50 Have 40% Higher Odds of Heart Disease, National Survey Finds
Cannabis use heart disease risk is notably higher in daily users under 50, with a 40% increase in odds compared to non-users. This national survey reveals a dose-response relationship between cannabis use and heart disease. The findings underscore the…
Most Medical Cannabis Users Also Use Recreationally, Pre-Legalization Canadian Study Finds
A large Canadian study reveals medical recreational cannabis overlap is common pre-legalization, with most medical users also consuming recreationally. This dual use pattern associates with higher psychiatric symptoms and more frequent cannabis use.…
Daily Cannabis Use and Moderate-to-Severe Use Disorder Risk in Primary Care
Cannabis use disorder prevalence increases with frequency of use, especially among daily users in primary care. This study highlights a 1-in-5 chance of moderate-to-severe disorder among daily cannabis users. Understanding cannabis use disorder…
Cannabis Use and Depression: What a Large National Survey Can and Cannot Tell Us
Cannabis use and depression are linked across all frequency levels, including mild use, according to a large national survey. This study highlights the importance of screening for depression regardless of cannabis use intensity. However, causal…
Mamedica Data Reveals 66% of Brits Report Cannabis Use
Mamedica cannabis use UK data reveals that 66% of British adults report cannabis use, suggesting significant underreporting in clinical settings. This prevalence has important implications for patient disclosure and clinical assessment in UK healthcare.…
Medically Recommended Cannabis Use for US Adolescents.
This study examines medically recommended cannabis use adolescents using nationally representative data. It reveals 5.2% of adolescent cannabis users have medical recommendations. Understanding medically recommended cannabis use adolescents informs…
Five Distinct Patterns of Prescription Drug Misuse Sources Identified Among US Teens
Adolescent prescription drug misuse involves obtaining drugs from multiple sources, each linked to different risk profiles. This study identifies five distinct patterns among US teens. Understanding these patterns helps tailor prevention and clinical…
Prevalence and Factors Associated with Alcohol and Illicit Drug Use Among Brazilian Youth
This study examined prevalence alcohol illicit drug use brazilian youth aged 16 to 25 during the transition to adulthood. A multicenter, cross-sectional survey revealed high rates of alcohol and illicit drug use, with cannabis being the most common…
Nearly 4 in 10 Young Lung Cancer Patients Also Smoked Cannabis—and Their Cancers Were More Aggressive
Cannabis tobacco dual smoking lung cancer is linked to more aggressive tumors in young patients. A French cohort study found nearly 4 in 10 young lung cancer patients smoked both substances. This dual smoking group showed earlier diagnosis and higher…